Moehs has exhibited in the event CPhI Istanbul 2015 in Turkey. The country that links Asia and Europe. The event hosted more than 200 exhibitors and attracted more than 4,000 visitors from the region looking for suppliers and manufacturing partners to bring cost-competitive pharmaceuticals to their individual markets.

Moehs exhibits at the event Pharmatec Africa on 11th, 12th and 13th February, the exhibition 100% about  pharma that takes places in Accra, Ghana. Another year, Moehs attends the DCAT fair on March 16 -19 in New York. This year, the 125th Anniversary of this organization in commemorated. Furthermore, also attends the international CPhI Japan

Moehs Catalana, S.L. was audited by the Gobernment of Catalonia – Spain in October 2014. From the knowledge gained during inspection, it is again confirmed  that the plant complies with Good Manufacturing Practice requirements and has been granted with the new GMP certificate. In addition, other plants of Moehs group have been audited to renew

According to EU Directive 2011/62/EU, as of 2nd July 2013, all the active substances imported in the European Union must have been manufactured in compliance with standards of good manufacturing practices (GMP), this compliance must be confirmed in writing by the competent authority of the exporting country. The AEM (European Drug Agency) has created a

Moehs BCN, S.L. is the new production Moehs group plant. It is located in the municipality of Castellbisbal, 30 km from Barcelona and 10 km from Catalana Moehs plant. Occupying a total area of 28,750 m², the production building has a total area of 4,500 m2, the sewage plant 2210 m2 and 2930 m² warehouse.

The FDA has recently inspected our plants. The result has been positive and our facilities have been approved successfully: Moehs Catalana: inspected in May 2013 Moehs Cantabra: inspected in March 2012 Coprima: inspected in November 2012 Benechim: inspection in June 2013